Get the Stockscreener App
25.66
0.27%
0.07
After Hours:
25.53
-0.13
-0.51%
Progyny Inc stock is traded at $25.66, with a volume of 765.03K.
It is up +0.27% in the last 24 hours and down -17.57% over the past month.
Progyny Inc is a benefits management company specializing in fertility, family building, and women's health benefits solutions. Its clients include employers across various industries. The fertility benefits solution consists of treatment services (Smart Cycles), access to the Progyny network of high-quality fertility specialists that perform the Smart Cycle treatments, and active management of the selective network of high-quality provider clinics.
See More
Previous Close:
$25.59
Open:
$25.49
24h Volume:
765.03K
Relative Volume:
0.59
Market Cap:
$1.97B
Revenue:
$1.29B
Net Income/Loss:
$67.69M
P/E Ratio:
33.32
EPS:
0.7701
Net Cash Flow:
$184.42M
1W Performance:
-0.62%
1M Performance:
-17.57%
6M Performance:
+45.05%
1Y Performance:
+8.41%
1-Day Range:
$25.46
$26.09
1-Week Range:
$25.46
$26.49
52-Week Range:
$16.10
$33.06
Progyny Inc Stock (PGNY) Company Profile
Name
Progyny Inc
Sector
Industry
Phone
212-888-3124
Address
1359 BROADWAY, NEW YORK, NY
Compare PGNY vs UNH, CVS, ELV, CI, HUM
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
PGNY
Progyny Inc
|
25.66 | 1.99B | 1.29B | 67.69M | 184.42M | 0.7701 |
UNH
Unitedhealth Group Inc
|
396.30 | 345.44B | 450.13B | 14.91B | 23.62B | 15.55 |
CVS
Cvs Health Corp
|
97.60 | 119.78B | 407.94B | 2.90B | 7.39B | 2.2771 |
ELV
Elevance Health Inc
|
403.04 | 85.94B | 201.11B | 4.95B | 6.29B | 22.50 |
CI
Cigna Group
|
283.06 | 72.51B | 278.13B | 6.74B | 7.66B | 23.60 |
HUM
Humana Inc
|
394.88 | 45.72B | 137.20B | 1.15B | 1.27B | 9.3439 |
Progyny Inc Stock (PGNY) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-20-26 | Upgrade | Citizens JMP | Mkt Perform → Mkt Outperform |
| Jan-08-26 | Upgrade | Truist | Hold → Buy |
| Dec-09-25 | Initiated | Barclays | Overweight |
| Nov-12-25 | Upgrade | KeyBanc Capital Markets | Sector Weight → Overweight |
| Jul-08-25 | Upgrade | Leerink Partners | Market Perform → Outperform |
| Dec-02-24 | Downgrade | JP Morgan | Overweight → Neutral |
| Nov-13-24 | Downgrade | Truist | Buy → Hold |
| Sep-19-24 | Downgrade | JMP Securities | Mkt Outperform → Mkt Perform |
| Aug-07-24 | Downgrade | BTIG Research | Buy → Neutral |
| Aug-07-24 | Downgrade | Canaccord Genuity | Buy → Hold |
| Aug-07-24 | Downgrade | Leerink Partners | Outperform → Market Perform |
| Jul-16-24 | Initiated | JMP Securities | Mkt Outperform |
| May-10-24 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| Feb-26-24 | Initiated | Leerink Partners | Outperform |
| Jan-03-24 | Initiated | Barclays | Overweight |
| Sep-27-23 | Initiated | Canaccord Genuity | Buy |
| May-22-23 | Initiated | BTIG Research | Buy |
| Apr-21-23 | Initiated | Cantor Fitzgerald | Overweight |
| Jan-05-23 | Downgrade | SVB Leerink | Outperform → Mkt Perform |
| Sep-16-22 | Initiated | KeyBanc Capital Markets | Overweight |
| Sep-07-22 | Initiated | Truist | Buy |
| Dec-02-21 | Initiated | Jefferies | Buy |
| Nov-22-21 | Downgrade | Citigroup | Buy → Neutral |
| Sep-30-21 | Initiated | Berenberg | Buy |
| Aug-12-21 | Initiated | Barclays | Overweight |
| Jun-02-21 | Downgrade | Guggenheim | Buy → Neutral |
| Apr-29-21 | Resumed | JP Morgan | Overweight |
| Mar-10-21 | Upgrade | BofA Securities | Neutral → Buy |
| Jul-01-20 | Initiated | SVB Leerink | Outperform |
| Jun-02-20 | Initiated | Guggenheim | Buy |
| Nov-19-19 | Initiated | Citigroup | Buy |
| Nov-19-19 | Initiated | Goldman | Buy |
| Nov-19-19 | Initiated | JP Morgan | Overweight |
| Nov-19-19 | Initiated | Piper Jaffray | Overweight |
| Nov-19-19 | Initiated | SVB Leerink | Outperform |
View All
Progyny Inc Stock (PGNY) Latest News
Progyny (NASDAQ:PGNY) Healthcare Innovation Gains Attention - Kalkine Media
PGNY Maintained by JP Morgan -- Price Target Raised to $30.00 - GuruFocus
JPMorgan Chase & Co. Boosts Progyny (NASDAQ:PGNY) Price Target to $30.00 - MarketBeat
Progyny (NASDAQ:PGNY) Upgraded at Wells Fargo & Company - MarketBeat
Tocqueville Asset Management L.P. Takes Position in Progyny, Inc. $PGNY - MarketBeat
Danske Bank A S Purchases Shares of 528,717 Progyny, Inc. $PGNY - MarketBeat
PGNY Initiated Coverage by Wells Fargo -- Rating Overweight Anno - GuruFocus
Progyny (PGNY) Q2 2026 Earnings Call Transcript - AOL.com
Wells Fargo Initiates Progyny at Overweight With $37 Price Target - marketscreener.com
Wells Fargo Initiates Progyny(PGNY.US) With Buy Rating, Announces Target Price $37 - Moomoo
Progyny (NASDAQ:PGNY): A Decent Value Stock Combining Reasonable Valuation and Solid Fundamentals - ChartMill
Bank of America Corp DE Grows Stake in Progyny, Inc. $PGNY - MarketBeat
Progyny (PGNY) Session Brief: Gains 1.76% to Reach $25.77 at the Close; Chart Reference: the Current Price Sits Inside the Supplied Technical Range in the Current UpdateMoving Average Ribbon - vinanet.vn
symbol__ Stock Quote Price and Forecast - CNN
Discipline and Rules-Based Execution in PGNY Response - Stock Traders Daily
Progyny Sees Utilization Rebound as Early Renewals De-Risk Outlook - marketbeat.com
Royal Bank of Canada Has $3.71 Million Stock Position in Progyny, Inc. $PGNY - MarketBeat
The 5 Most Interesting Analyst Questions From Progyny’s Q2 Earnings Call - Yahoo Finance
Truist Financial Maintains Progyny(PGNY.US) With Buy Rating, Announces Target Price $36 - moomoo.com
PGNY Maintains Buy Rating -- Price Target Raised to $36.00 by Tr - GuruFocus
Truist raises Progyny price target to $36 after strong Q2 results and growing institutional support - Pluang
Truist Adjusts Price Target on Progyny to $36 From $33, Maintains Buy Rating - Moomoo
Progyny Inc (PGNY) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Progyny, Inc. (PGNY) Stock Forecasts - Yahoo Finance
PGNY Maintains Rating by Barclays -- Price Target Lowered to $30 - GuruFocus
Sei Investments Co. Decreases Stake in Progyny, Inc. $PGNY - MarketBeat
Progyny Inc (PGNY) Stock Down 4.6% -- Now Undervalued? GF Score: 93/100 - GuruFocus
Progyny Drops 5.4% Amid Sector-Wide Selling - AlphaStreet
Progyny, Inc. $PGNY Shares Sold by Janus Henderson Group PLC - MarketBeat
Progyny, Inc. (PGNY) Stock Analysis: Examining The 21% Potential Upside - DirectorsTalk Interviews
Why Progyny (PGNY) Shares Are Sliding Today - finance.yahoo.com
Progyny (PGNY) Stock May Still Trade At A Discount As Earnings Hold Up - Yahoo Finance
Quantinno Capital Management LP Grows Position in Progyny, Inc. $PGNY - MarketBeat
PGNY Q2 CY2026 Deep Dive: Seasonality and Guidance Weigh on Positive Underlying Performance - Yahoo Finance
Analysts Offer Insights on Healthcare Companies: Progyny (PGNY), Scholar Rock Holding (SRRK) and Ascendis Pharma (ASND) - The Globe and Mail
A Quick Look at Today's Ratings for Progyny(PGNY.US), With a Forecast Between $31 to $35 - Moomoo
Progyny (PGNY) Stock Sinks As Guidance Jitters Clash With Margin Strength - simplywall.st
PGNY SWOT Analysis: Strong Growth Potential Revealed in 10-Q Fil - GuruFocus
Progyny Inc (PGNY) Stock News Today - TradingKey
Progyny Posts Record Q2 Results, Expands Client Base - The Globe and Mail
CCORF Maintains Progyny(PGNY.US) With Buy Rating, Cuts Target Price to $35 - moomoo.com
Progyny, Inc. Releases Q2 2026 Form 10-Q Filing Highlighting Financials and Risks - kalkinemedia.com
Why Progyny Stock Plunged, Then Gradually Recovered Today - AOL.com
Progyny CEO to present at Canaccord Genuity Ann... - Pluang
Progyny (NASDAQ:PGNY) Shares Gap DownHere's What Happened - MarketBeat
Progyny, Inc. to Present at the Canaccord Genuity Annual Growth Conference - GlobeNewswire
Progyny, Inc. 2026: Revenue $350.51M, EPS $0.34— 10-Q Summary - TradingView
Progyny, Inc. Q2 2026 Earnings Call Summary - Yahoo Finance
Progyny, Inc. Stock 12‑Month Price Target Cut to $33.82, Implies 12% Upside - TradingView
Progyny Q2 2026 Earnings Call Transcript - MarketBeat
Progyny, Inc. 2026 Q2ResultsEarnings Call Presentation (NASDAQ:PGNY) 2026-08-07 - Seeking Alpha
Progyny Inc Stock (PGNY) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.42%
0.43%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):